Literature DB >> 8476116

Organ specificity of the dopamine1 receptor/adenylyl cyclase coupling defect in spontaneously hypertensive rats.

R A Felder1, S Kinoshita, K Ohbu, M M Mouradian, D R Sibley, F J Monsma, T Minowa, M T Minowa, L M Canessa, P A Jose.   

Abstract

The coupling between the dopamine1 (DA1) receptor and the G protein/adenylyl cyclase (AC) enzyme complex is defective in the proximal convoluted tubule (PCT) of 20-wk-old spontaneously hypertensive rats (SHRs). Because this coupling defect could have been due to desensitization secondary to elevated renal dopamine levels in the adult animal, we studied the interaction between DA1 receptors and AC in PCT of rats as early as 3 wk of age, a time when renal dopamine levels are similar in SHRs and their normotensive controls (Wistar-Kyoto rats, WKYs). Maximum receptor density did not change with age and was similar in WKYs and SHRs in all the age groups studied (3, 8, and 20 wk). Basal-, forskolin-, and guanyl nucleotide-stimulated AC activities were also similar in WKYs and SHRs and did not change with age. However, the DA1 agonist-stimulated AC activity was greater in WKYs than in SHRs and increased with age in WKYs but not in SHRs. Moreover, the ability of a nonhydrolyzable analogue of GTP, Gpp(NH)p, to enhance DA1 agonist (SND-919-C12, 1 microM)-stimulated AC activity increased with age in WKY but not in SHRs. To determine if the defect noted in the PCT of SHRs is due to a defective D1A receptor gene, parallel studies were performed in the striatum, since this receptor is expressed predominantly in the latter tissue. In contrast to the results in PCT, radioligand binding and AC studies in striatum revealed no differences between WKYs and SHRs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476116     DOI: 10.1152/ajpregu.1993.264.4.R726

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  G protein-coupled receptor kinase 4: role in blood pressure regulation.

Authors:  Chunyu Zeng; Van Anthony M Villar; Gilbert M Eisner; Scott M Williams; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

2.  Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane.

Authors:  H Brismar; M Asghar; R M Carey; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 3.  Dopamine receptor-coupling defect in hypertension.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

4.  The Dopamine D1 Receptor and Angiotensin II Type-2 Receptor are Required for Inhibition of Sodium Transport Through a Protein Phosphatase 2A Pathway.

Authors:  John J Gildea; Peng Xu; Brandon A Kemp; Robert M Carey; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 5.  Renal dopamine and sodium homeostasis.

Authors:  P A Jose; G M Eisner; R A Felder
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

6.  Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension.

Authors:  C Chatziantoniou; X Ruan; W J Arendshorst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells.

Authors:  Rui Pedrosa; Pedro Gomes; Chunyu Zeng; Ulrich Hopfer; Pedro A Jose; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

Review 8.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

9.  Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension.

Authors:  F E Albrecht; J Drago; R A Felder; M P Printz; G M Eisner; J E Robillard; D R Sibley; H J Westphal; P A Jose
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 10.  Dopaminergic defect in hypertension.

Authors:  P A Jose; G M Eisner; R A Felder
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.